# Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

> **NCT02324205** · NA · TERMINATED · sponsor: **GE Healthcare** · enrollment: 196 (actual)

## Conditions studied

- Breast Cancer
- Tumors, Breast

## Interventions

- **DEVICE:** DBT and FFDM

## Key facts

- **NCT ID:** NCT02324205
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2017-08-29
- **Final completion:** 2017-08-29
- **Target enrollment:** 196 (ACTUAL)
- **Why stopped:** Sponsor met enroll. need for planned second study before meeting enroll. ceiling in protocol
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324205, "Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02324205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*